KD Logo

HSBC Securities upgrades Moderna Inc (MRNA) rating to a Buy

Moderna Inc’s recently made public that its President Hoge Stephen unloaded Company’s shares for reported $12771.0 on Nov 11 ’24. In the deal valued at $46.10 per share,277 shares were sold. As a result of this transaction, Hoge Stephen now holds 1,443,248 shares worth roughly $57.02 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Hoge Stephen bought 277 shares, generating $12,771 in total proceeds.

Before that, Mock James M sold 715 shares. Moderna Inc shares valued at $42,986 were divested by the Chief Financial Officer at a price of $60.12 per share. As a result of the transaction, Mock James M now holds 9,505 shares, worth roughly $0.38 million.

HSBC Securities upgraded its Moderna Inc [MRNA] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who began to cover the stock in mid November with a ‘”an Underperform”‘ rating. Bernstein began covering MRNA with “Mkt perform” recommendation on October 17, 2024. Oppenheimer revised its rating on September 13, 2024. It rated MRNA as “a Perform” which previously was an “an Outperform”.

Price Performance Review of MRNA

On Monday, Moderna Inc [NASDAQ:MRNA] saw its stock jump 7.22% to $39.51. Over the last five days, the stock has lost -7.58%. Moderna Inc shares have fallen nearly -60.27% since the year began. Nevertheless, the stocks have fallen -48.39% over the past one year. While a 52-week high of $170.47 was reached on 05/24/24, a 52-week low of $35.80 was recorded on 11/15/24. SMA at 50 days reached $57.82, while 200 days put it at $97.28.

Levels Of Support And Resistance For MRNA Stock

The 24-hour chart illustrates a support level at 37.82, which if violated will result in even more drops to 36.13. On the upside, there is a resistance level at 40.48. A further resistance level may holdings at 41.46. The Relative Strength Index (RSI) on the 14-day chart is 23.12, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -8.72, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 82.24%. Stochastics %K at 9.30% indicates the stock is a buying.

How much short interest is there in Moderna Inc?

A steep rise in short interest was recorded in Moderna Inc stocks on 2024-10-31, growing by 3.06 million shares to a total of 34.38 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 31.32 million shares. There was a rise of 8.9%, which implies that there is a positive sentiment for the stock.

Most Popular